Articles by John Towns - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by John Towns

John Towns


John Towns is the senior director of global CMC regulatory affairs at Eli Lilly and Company. Towns is also the chair of the Quality by Design Working Group of the PhRMA Biologics and Biotechnology Leadership Committee

Quality by Design for Biotechnology Products—Part 1
November 1, 2009

First in a three-part series that discusses the complexities of QbD implementation in biotech product development.

ADVERTISEMENT

ADVERTISEMENT

Click here